articleScienceDec 5, 2019Closed access

Design of an in vitro biocatalytic cascade for the manufacture of islatravir

Merck & Co., Inc., Rahway, NJ, USA (United States) · Codexis (United States)

PubMed
Indexed incrossrefpubmed

Abstract

Enzyme-catalyzed reactions have begun to transform pharmaceutical manufacturing, offering levels of selectivity and tunability that can dramatically improve chemical synthesis. Combining enzymatic reactions into multistep biocatalytic cascades brings additional benefits. Cascades avoid the waste generated by purification of intermediates. They also allow reactions to be linked together to overcome an unfavorable equilibrium or avoid the accumulation of unstable or inhibitory intermediates. We report an in vitro biocatalytic cascade synthesis of the investigational HIV treatment islatravir. Five enzymes were engineered through directed evolution to act on non-natural substrates. These were combined with four…

No related works found for this paper.